Cite
HARVARD Citation
Oberlé, M. et al. (2022). Response to BRAF and MEK Inhibitors in BRAF Thr599dup–Mutated Melanoma. JCO precision oncology. p. . [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Oberlé, M. et al. (2022). Response to BRAF and MEK Inhibitors in BRAF Thr599dup–Mutated Melanoma. JCO precision oncology. p. . [Online].